COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT03820258
Brief Title: Pharmacokinetics, Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) Fixed Dose Combination (FDC) in Adolescents and Children With Chronic Hepatitis C Virus (HCV) Infection

First Submitted : January 14, 2019
First Submitted that Met QC Criteria : January 25, 2019
First Posted : January 29, 2019

Last Update Submitted that Met QC Criteria : March 20, 2020
Last Update Posted : March 24, 2020